Novo Nordisk Research and Development Expenses 2012-2026 | NVO
Novo Nordisk research and development expenses for the twelve months ending March 31, 2026 were $8.035B, a 12.05% increase year-over-year.
- Novo Nordisk annual research and development expenses for 2025 were $7.879B, a 13.05% increase from 2024.
- Novo Nordisk annual research and development expenses for 2024 were $6.969B, a 47.94% increase from 2023.
- Novo Nordisk annual research and development expenses for 2023 were $4.711B, a 38.35% increase from 2022.